Boniva Ad Campaign Prompts Procter & Gamble/Sanofi-Aventis Suit
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble and Sanofi-Aventis have filed suit over an ad campaign used by Roche and GlaxoSmithKline for promotion of their osteoporosis therapy Boniva (ibandronate)
You may also be interested in...
Sanofi/P&G Package Actonel Osteoporosis Therapy With Calcium
Packaging for Sanofi-Aventis/Procter & Gamble's Actonel with Calcium is aimed at ensuring dosing compliance for the bisphosphonate/dietary supplement osteoporosis treatment regimen
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands